Found: 1141
Select item for more details and to access through your institution.
Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 10, p. 1523, doi. 10.1007/s00228-024-03719-0
- By:
- Publication type:
- Article
Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2515, doi. 10.1093/rheumatology/keae196
- By:
- Publication type:
- Article
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2535, doi. 10.1093/rheumatology/keae180
- By:
- Publication type:
- Article
Comment on: Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis. Reply.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Use of biological disease modifying antirheumatic drugs in rheumatoid arthritis in Austria from 2008 to 2011.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 7/8, p. 230, doi. 10.1007/s00508-018-1321-4
- By:
- Publication type:
- Article
Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis.
- Published in:
- Infection, 2023, v. 51, n. 6, p. 1619, doi. 10.1007/s15010-023-02047-2
- By:
- Publication type:
- Article
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort.
- Published in:
- Infection, 2023, v. 51, n. 4, p. 851, doi. 10.1007/s15010-022-01915-7
- By:
- Publication type:
- Article
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study.
- Published in:
- Infection, 2023, v. 51, n. 1, p. 129, doi. 10.1007/s15010-022-01853-4
- By:
- Publication type:
- Article
Multicentric Castleman's disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018.
- Published in:
- Infection, 2021, v. 49, n. 5, p. 945, doi. 10.1007/s15010-021-01618-5
- By:
- Publication type:
- Article
Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Successful Management of Cytokine Storm Induced Acute Respiratory Distress Syndrome Secondary to H1N1 Influenza with Tocilizumab.
- Published in:
- Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2023, v. 16, n. 4, p. 648, doi. 10.4103/mjdrdypu.mjdrdypu_1071_22
- By:
- Publication type:
- Article
Evaluating the Effects of Nebulized Tocilizumab versus Intravenous Tocilizumab in the Management of Severe Coronavirus Disease 2019 Cases: A Randomized Clinical Trial.
- Published in:
- Biomedical & Biotechnology Research Journal, 2023, v. 7, n. 3, p. 504, doi. 10.4103/bbrj.bbrj_152_23
- By:
- Publication type:
- Article
Difficulties in the diagnosis of erysipelas in immunosuppressed patients.
- Published in:
- Forum Dermatologicum, 2024, v. 10, n. 1, p. 24, doi. 10.5603/fd.96995
- By:
- Publication type:
- Article
Long-term patency of aorto-biiliac endoprosthesis for critical lower limb ischaemia in Takayasu arteritis after complicated angioplasty with a drug-coated balloon: Effect of dual antiplatelet therapy combined with tocilizumab.
- Published in:
- Modern Rheumatology Case Reports, 2024, v. 8, n. 1, p. 101, doi. 10.1093/mrcr/rxad030
- By:
- Publication type:
- Article
Successful peficitinib monotherapy for the new-onset skin manifestations of rheumatoid vasculitis after long-term treatment with tocilizumab for rheumatoid arthritis.
- Published in:
- Modern Rheumatology Case Reports, 2024, v. 8, n. 1, p. 5, doi. 10.1093/mrcr/rxad025
- By:
- Publication type:
- Article
A case of TAFRO syndrome maintained in remission for 5 years after discontinuation of tocilizumab.
- Published in:
- Modern Rheumatology Case Reports, 2023, v. 7, n. 1, p. 205, doi. 10.1093/mrcr/rxac007
- By:
- Publication type:
- Article
Tocilizumab for juvenile Takayasu arteritis complicated with acute heart failure at onset.
- Published in:
- Modern Rheumatology Case Reports, 2022, v. 6, n. 2, p. 226, doi. 10.1093/mrcr/rxab036
- By:
- Publication type:
- Article
A new therapeutic approach with tocilizumab in a 39-year-old patient with recurrent diabetic myonecrosis.
- Published in:
- Modern Rheumatology Case Reports, 2022, v. 6, n. 1, p. 59, doi. 10.1093/mrcr/rxab016
- By:
- Publication type:
- Article
Effectiveness of subcutaneous tocilizumab in refractory adult Still's disease: report of three cases and a review of the literature.
- Published in:
- Modern Rheumatology Case Reports, 2021, v. 5, n. 2, p. 365, doi. 10.1080/24725625.2021.1886402
- By:
- Publication type:
- Article
Reintroduction of tocilizumab elicited macrophage activation syndrome in a patient with adult-onset Still's disease with a previous successful tocilizumab treatment.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab.
- Published in:
- Modern Rheumatology Case Reports, 2021, v. 5, n. 1, p. 145, doi. 10.1080/24725625.2020.1789304
- By:
- Publication type:
- Article
Successful use of short-term add-on tocilizumab for refractory adult-onset still's disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Rosai-Dorfman disease with aortic involvement in a 58-year-old man: a case report.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Remarkable effectiveness of tocilizumab in familial Mediterranean fever exon 3 variant with severe abdominal pain and PFAPA-like symptoms: a child case report and review of the literature.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Development of adult T-cell leukaemia/lymphoma during the treatment of rheumatoid arthritis.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Tocilizumab prevents renal function of a patient with diabetic kidney disease: case report.
- Published in:
- Modern Rheumatology Case Reports, 2019, v. 3, n. 1, p. 53, doi. 10.1080/24725625.2018.1477489
- By:
- Publication type:
- Article
Successful treatment with tocilizumab monotherapy for Takayasu arteritis developing during infliximab therapy in a patient with ulcerative colitis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
A case of TAFRO syndrome successfully treated with cyclosporin A and tocilizumab.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Life after tocilizumab given for giant cell arteritis: a patient survey and argument for re-treatment.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae054
- By:
- Publication type:
- Article
Comment on: Benchmarking tocilizumab use for giant cell arteritis.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac038
- By:
- Publication type:
- Article
Benchmarking tocilizumab use for giant cell arteritis.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac037
- By:
- Publication type:
- Article
autoinflammatory syndrome with compound heterozygous MEFV and NOD2/CARD15 gene mutations successfully treated with tocilizumab.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 2, p. 1, doi. 10.1093/rap/rkac035
- By:
- Publication type:
- Article
Tocilizumab for the treatment of giant cell arteritis in Scotland: a report on behalf of the Scottish Society for Rheumatology standards subgroup.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac017
- By:
- Publication type:
- Article
Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac002
- By:
- Publication type:
- Article
Throat swelling following tocilizumab infusion—not always angioedema.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Long-term treatment with tocilizumab in giant cell arteritis: efficacy and safety in a monocentric cohort of patients.
- Published in:
- Rheumatology Advances in Practice, 2020, v. 4, n. 2, p. 1, doi. 10.1093/rap/rkaa017
- By:
- Publication type:
- Article
Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label study.
- Published in:
- Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rkz010
- By:
- Publication type:
- Article
Severe destructive arthritis in adult-onset Still's disease.
- Published in:
- Rheumatology Advances in Practice, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1093/rap/rky052
- By:
- Publication type:
- Article
A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 7, p. 1025, doi. 10.3390/healthcare11071025
- By:
- Publication type:
- Article
Clinical Consequences for Individuals Treated with Tocilizumab for Serious COVID-19 Infection.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 4, p. 607, doi. 10.3390/healthcare11040607
- By:
- Publication type:
- Article
The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection.
- Published in:
- Healthcare (2227-9032), 2023, v. 11, n. 4, p. 487, doi. 10.3390/healthcare11040487
- By:
- Publication type:
- Article
A successful antenatal outcome in a patient with refractory Takayasu's arteritis treated with tocilizumab throughout pregnancy—a case report.
- Published in:
- Oxford Medical Case Reports, 2023, v. 2023, n. 5, p. 1, doi. 10.1093/omcr/omad046
- By:
- Publication type:
- Article
Halo naevi, vitiligo and diffuse alopecia areata associated with tocilizumab therapy.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
P1‐65: Two cases of Castleman's disease with lung lesions controlled by tocilizumab.
- Published in:
- Respirology, 2021, v. 26, p. 100, doi. 10.1111/resp.14150_65
- Publication type:
- Article
P5‐122: A case of secondary organizing pneumonia caused by relapse of inflammation after COVID‐19 treatment with systemic corticosteroid and tocilizumab.
- Published in:
- Respirology, 2021, v. 26, p. 207, doi. 10.1111/resp.14150_329
- Publication type:
- Article
P5‐76: Prolonged viral clearance in COVID‐19 patients treated with tocilizumab.
- Published in:
- Respirology, 2021, v. 26, p. 187, doi. 10.1111/resp.14150_283
- Publication type:
- Article
P5‐58: Efficacy of concurrent administration of tocilizumab with corticosteroids for patients with COVID‐19.
- Published in:
- Respirology, 2021, v. 26, p. 180, doi. 10.1111/resp.14150_265
- Publication type:
- Article
P1‐65: Two cases of Castleman's disease with lung lesions controlled by tocilizumab.
- Published in:
- Respirology, 2021, v. 26, p. 100, doi. 10.1111/resp.14150_65
- Publication type:
- Article